Search research articles
Contact Us
Filters
Showing results (221-230 of 249) with videos related to
Page
of 25
Sort By:
Cancer
|
July 22, 2015
Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial
Anna M Sawka, Sharon Straus, Gary Rodin, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 21, 2007
Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis
Shoba Subramanian, David P Goldstein, Luciana Parlea, et al.
Cell Metabolism
|
October 7, 2020
Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes
Shereen Ezzat, Lei Zheng, Jose C Florez, et al.
Clinical Endocrinology
|
February 21, 2008
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors
Anna M Sawka, Deepak C Lakra, Jane Lea, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 21, 2021
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification
Sylvia L Asa, Ozgur Mete, Michael D Cusimano, et al.
Cell Metabolism
|
June 11, 2013
The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes
Shereen Ezzat, Lei Zheng, Jose C Florez, et al.
The American Journal of Surgical Pathology
|
November 1, 2018
Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease
Sylvia L Asa, Shereen Ezzat, Daniel F Kelly, et al.
Frontiers in Oncology
|
November 19, 2024
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma
Shereen Ezzat, Jesse D Pasternak, Murali Rajaraman, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 30, 2018
A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer
Chi Yun Yu, Omar Saeed, Alyse S Goldberg, et al.
European Journal of Haematology
|
October 13, 2020
Prolactin, a potential biomarker for chronic GVHD activity
Maria Queralt Salas, Shereen Ezzat, Wilson Lam, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 249) with videos related to
Sort By:
Page
of 25
Cancer
|
July 22, 2015
Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial
Anna M Sawka, Sharon Straus, Gary Rodin, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 21, 2007
Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis
Shoba Subramanian, David P Goldstein, Luciana Parlea, et al.
Cell Metabolism
|
October 7, 2020
Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes
Shereen Ezzat, Lei Zheng, Jose C Florez, et al.
Clinical Endocrinology
|
February 21, 2008
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors
Anna M Sawka, Deepak C Lakra, Jane Lea, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 21, 2021
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification
Sylvia L Asa, Ozgur Mete, Michael D Cusimano, et al.
Cell Metabolism
|
June 11, 2013
The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes
Shereen Ezzat, Lei Zheng, Jose C Florez, et al.
The American Journal of Surgical Pathology
|
November 1, 2018
Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease
Sylvia L Asa, Shereen Ezzat, Daniel F Kelly, et al.
Frontiers in Oncology
|
November 19, 2024
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma
Shereen Ezzat, Jesse D Pasternak, Murali Rajaraman, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 30, 2018
A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer
Chi Yun Yu, Omar Saeed, Alyse S Goldberg, et al.
European Journal of Haematology
|
October 13, 2020
Prolactin, a potential biomarker for chronic GVHD activity
Maria Queralt Salas, Shereen Ezzat, Wilson Lam, et al.
Page
of 25